Most Recent
Construction PRO
Watpac sues insurer over $4M claim for late works at Casey Hospital
The builder contracted to carry out expansion works at Casey Hospital in Berwick has sued its insurer for refusing to cover $4 million in damages caused by a subcontractor's delays.
Plastic surgeon can’t escape class action despite applicant dropping claims
A class action over alleged botched cosmetic surgeries can drop claims against one surgeon, but the doctor will remain a party so other defendants can point the finger at him.
Beckman Coulter shoots down biotech’s stem cell trade mark
US lab products giant Beckman Coulter has successfully opposed an Australian biotech's bid to trade mark ‘Cytophex’ for its stem cell expansion system, with an IP Australia delegate finding the mark is too similar to Beckman's ‘CytoFLEX’ mark. 
Construction PRO
Multiplex tapped for Canberra’s $1B Northside Hospital project
The ACT government’s has appointed Multiplex to support design and planning work for the next stage of the territory's northside hospital project in Canberra.
DePuy class action group member appeals failed challenge to payout
A group member in a class action against Johnson & Johnson unit DePuy has filed an appeal after he lost a challenge to his compensation determination, 12 years after the case settled.
Junior doctors class actions settle with Victorian hospitals for $175M
A group of class actions against healthcare providers in Victoria that allegedly failed to pay junior doctors for overtime have settled for $175 million. 
Law firm defending junior doctors class actions might get a lot busier
Victorian healthcare providers facing class actions on behalf of junior doctors have turned to one law firm to lead their defence. And that firm might be about to get a lot busier.
Bayer class action wants to know bill for failed case before deciding on appeal
The plaintiff in an unsuccessful class action against Bayer over its Essure contraceptive device wants to see whether she can avoid paying costs in the case before deciding on whether to appeal the loss.
Lundbeck, Sandoz end long-running Lexapro patent war
Pharmaceutical giant Lundbeck has resolved its battle with Novartis unit Sandoz over top-selling drug Lexapro, a battle that has raged for years and across multiple courts.